Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
It’s not often that a company with the scale and…
Sell
39
BBIO Quote, Financials, Valuation and Earnings
Last price:
$26.49
Seasonality move
:
-20.12%
Day range:
$26.02 - $26.90
52-week range:
$21.62 - $44.32
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
22.18x
P/B ratio:
--
Volume:
4M
Avg. volume:
2.5M
1-year change:
-30.64%
Market cap:
$5B
Revenue:
$9.3M
EPS (TTM):
-$2.41
BBIO Analysts' Consensus Rating
The 11 analysts providing 12-month price projections for BridgeBio Pharma shares anticipate an average target of $48.56, ranging from a low estimate of $36.40 to a high estimate of $70.00. This average target implies a growth of 83.28% compared to the current stock price of $26.50.
Consensus Price Target
$48.56
Highest Price Target
$70.00
Lowest Price Target
$36.40
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Analyst Ratings
| 6M Ago | 1M Ago | Current | |
|---|---|---|---|
| Buy | 9 | 9 | 9 |
| Hold | 1 | 2 | 2 |
| Sell | 0 | 0 | 0 |
| Consensus | Buy | Buy | Buy |
BBIO Recommendation Trends
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Tyson Foods Stock Bounce Back?
Tyson Foods, Inc. (NYSE:TSN) is one of the biggest food…
Will Iovance Biotherapeutics Stock Bounce Back?
Iovance Biotherapeutics (NASDAQ:IOVA) is a fledgling pharmaceutical company that specializes…
Stock Ideas
Buy
64
Is AAPL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 42x
Buy
52
Is NVDA Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 113x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 37x
Alerts
Buy
61
QMCO alert for Dec 21
Quantum [QMCO] is up 26.28% over the past day.
Sell
46
NUKK alert for Dec 21
Nukkleus [NUKK] is down 22.94% over the past day.
Sell
1
IIPR alert for Dec 21
Innovative Industrial Properties [IIPR] is down 22.7% over the past day.
